{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T04:23:28Z","timestamp":1726719808797},"posted":{"date-parts":[[2023,9,8]]},"group-title":"In Review","reference-count":77,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T00:00:00Z","timestamp":1694131200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,8,12]]},"abstract":"<title>Abstract<\/title>\n        <p>Serum amyloid A (SAA) proteins increase dramatically in the blood following inflammation. Recently, SAAs are increased in humans following stroke and in ischemic animal models. However, the impact of SAAs on whether this signal is critical in the ischemic brain remains unknown. Therefore, we investigated the role of SAA and SAA signaling in the ischemic brain. Wildtype and SAA deficient mice were exposed to middle cerebral artery occlusion and reperfusion, examined for the impact of infarct volumes, behavioral changes, inflammatory markers, TUNEL staining, and BBB changes. The underlying mechanisms were investigated using SAA deficient mice, transgenic mice and viral vectors. SAA levels were significantly increase following MCAo and mice deficient in SAAs showed reduced infarct volumes and improved behavioral outcomes. SAA deficient mice showed a reduction in TUNEL staining, inflammation and decreased glial activation. Mice lacking acute phase SAAs demonstrated a reduction in expression of the NLRP3 inflammasome and SAA\/NLRP3 KO mice showed improvement. Restoration of SAA expression via SAA tg mice or adenoviral expression reestablished the detrimental effects of SAA. A reduction in BBB permeability was seen in the SAA KO mice and anti-SAA antibody treatment reduced the effects on ischemic injury. SAA signaling plays a critical role in regulating NLRP3-induced inflammation and glial activation in the ischemic brain. Blocking this signal will be a promising approach for treating ischemic stroke.<\/p>","DOI":"10.21203\/rs.3.rs-3258406\/v1","type":"posted-content","created":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T18:06:09Z","timestamp":1694196369000},"source":"Crossref","is-referenced-by-count":0,"title":["Serum amyloid A-dependent inflammasome activation and acute injury in a mouse model of experimental stroke"],"prefix":"10.21203","author":[{"given":"Jin","family":"Yu","sequence":"first","affiliation":[{"name":"University of South Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Zhu","sequence":"additional","affiliation":[{"name":"University of South Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeid","family":"Taheri","sequence":"additional","affiliation":[{"name":"University of South Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"June-Yong","family":"Lee","sequence":"additional","affiliation":[{"name":"New York University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Diamond","sequence":"additional","affiliation":[{"name":"University of South Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryl","family":"Kirstein","sequence":"additional","affiliation":[{"name":"University of South Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark S.","family":"Kindy","sequence":"additional","affiliation":[{"name":"University of South Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/ejcn.2013.30","article-title":"Impact of nutritional status and dietary quality on stroke: do we need specific recommendations?","volume":"67","author":"Lim H","year":"2013","unstructured":"Lim H, Choue R (2013) Impact of nutritional status and dietary quality on stroke: do we need specific recommendations? Eur J Clin Nutr 67:548\u201354.","journal-title":"Eur J Clin Nutr"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1016\/j.wneu.2011.07.023","article-title":"Epidemiology and the global burden of stroke","volume":"76","author":"Mukherjee D","year":"2011","unstructured":"Mukherjee D, Patil CG (2011) Epidemiology and the global burden of stroke. World Neurosurg 76:S85\u201390.","journal-title":"World Neurosurg"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.mehy.2013.11.024","article-title":"Neuroinflammation in ischemic brain injury as an adaptive process","volume":"82","author":"Rivers-Auty J","year":"2014","unstructured":"Rivers-Auty J, Ashton JC (2014) Neuroinflammation in ischemic brain injury as an adaptive process. Med. Hypotheses 82:151\u20138.","journal-title":"Med. Hypotheses"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1177\/0003319713506516","article-title":"Link between oxidative stress and acute brain ischemia","volume":"65","author":"Radak D","year":"2014","unstructured":"Radak D, Resanovic I, Isenovic ER (2014) Link between oxidative stress and acute brain ischemia. Angiology 65:667\u201376.","journal-title":"Angiology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/00004647-200101000-00002","article-title":"Reactive oxygen radicals in signaling and damage in the ischemic brain","volume":"21","author":"Chan PH","year":"2001","unstructured":"Chan PH Reactive oxygen radicals in signaling and damage in the ischemic brain. (2001) J Cereb Blood Flow Metab 21:2\u201314.","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s12035-010-8102-z","article-title":"Reperfusion and neurovascular dysfunction in stroke: from basic mechanisms to potential strategies for neuroprotection","volume":"41","author":"Jung JE","year":"2010","unstructured":"Jung JE, Kim GS, Chen H, Maier CM, Narasimhan P, Song YS, Niizuma K, Katsu M, Okami N, Yoshioka H, Sakata H, Goeders CE, Chan PH (2010) Reperfusion and neurovascular dysfunction in stroke: from basic mechanisms to potential strategies for neuroprotection. Mol Neurobiol 41:172\u20139.","journal-title":"Mol Neurobiol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2174\/187152411794961040","article-title":"p38 MAP kinase inhibitors as potential therapeutic drugs for neural diseases","volume":"11","author":"Yasuda S","year":"2011","unstructured":"Yasuda S, Sugiura H, Tanaka H, Takigami S, Yamagata K (2011) p38 MAP kinase inhibitors as potential therapeutic drugs for neural diseases. Cent Nerv Syst Agents Med Chem 11:45\u201359.","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1007\/s00018-012-1011-8","article-title":"NADPH oxidases as therapeutic targets in ischemic stroke","volume":"69","author":"Kahles T","year":"2012","unstructured":"Kahles T, Brandes RP (2012) NADPH oxidases as therapeutic targets in ischemic stroke. Cell Mol Life Sci 69:2345\u201363.","journal-title":"Cell Mol Life Sci"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00011-016-0981-7","article-title":"NLRP3 inflammasome: a promising target in ischemic stroke","volume":"66","author":"Gao L","year":"2017","unstructured":"Gao L, Dong Q, Song Z, Shen F, Shi J, Li Y (2017) NLRP3 inflammasome: a promising target in ischemic stroke. Inflamm Res 66:17\u201324.","journal-title":"Inflamm Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000452172","article-title":"Minocycline Suppresses NLRP3 Inflammasome Activation in Experimental Ischemic Stroke","volume":"23","author":"Lu Y","year":"2016","unstructured":"Lu Y, Xiao G, Luo W (2016) Minocycline Suppresses NLRP3 Inflammasome Activation in Experimental Ischemic Stroke. Neuroimmunomodulation 23:230\u2013238.","journal-title":"Neuroimmunomodulation"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/prca.201600028","article-title":"Acute phase proteins as promising biomarkers: Perspectives and limitations for human and veterinary medicine","volume":"10","author":"Schr\u00f6dl W","year":"2016","unstructured":"Schr\u00f6dl W, B\u00fcchler R, Wendler S, Reinhold P, Muckova P, Reindl J, Rhode H (2016) Acute phase proteins as promising biomarkers: Perspectives and limitations for human and veterinary medicine. Proteomics Clin Appl 10:1077\u20131092.","journal-title":"Proteomics Clin Appl"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1194\/jlr.M062174","article-title":"Impact of individual acute phase serum amyloid A isoforms on HDL metabolism in mice","volume":"57","author":"Kim MH","year":"2016","unstructured":"Kim MH, de Beer MC, Wroblewski JM, Charnigo RJ, Ji A, Webb NR, de Beer FC, van der Westhuyzen DR (2016) Impact of individual acute phase serum amyloid A isoforms on HDL metabolism in mice. J Lipid Res 57:969\u201379.","journal-title":"J Lipid Res"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1172\/JCI86401","article-title":"Serum amyloid A impairs the antiinflammatory properties of HDL","volume":"126","author":"Han CY","year":"2016","unstructured":"Han CY, Tang C, Guevara ME, Wei H, Wietecha T, Shao B, Subramanian S, Omer M, Wang S, O'Brien KD, Marcovina SM, Wight TN, Vaisar T, de Beer MC, de Beer FC, Osborne WR, Elkon KB, Chait A (2016) Serum amyloid A impairs the antiinflammatory properties of HDL. J Clin Invest 126:796.","journal-title":"J Clin Invest"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/MOL.0000000000000333","article-title":"Effect of inflammation on HDL structure and function","volume":"27","author":"Feingold KR","year":"2016","unstructured":"Feingold KR, Grunfeld C (2016) Effect of inflammation on HDL structure and function. Curr Opin Lipidol 27:521\u201330.","journal-title":"Curr Opin Lipidol"},{"issue":"7","key":"ref15","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s10571-020-00808-3","article-title":"Serum Amyloid A is Expressed in the Brain After Traumatic Brain Injury in a Sex-Dependent Manner","volume":"40","author":"Soriano S","year":"2020","unstructured":"Soriano S, Moffet B, Wicker E, Villapol S (2020) Serum Amyloid A is Expressed in the Brain After Traumatic Brain Injury in a Sex-Dependent Manner. Cell Mol Neurobiol 40(7):1199\u20131211.","journal-title":"Cell Mol Neurobiol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"100365","DOI":"10.1016\/j.jlr.2023.100365","article-title":"Serum amyloid A augments the atherogenic effects of cholesteryl ester transfer protein","volume":"64","author":"Ji A","year":"2023","unstructured":"Ji A, Trumbauer AC, Noffsinger VP, de Beer FC, Webb NR, Tannock LR, Shridas P (2023) Serum amyloid A augments the atherogenic effects of cholesteryl ester transfer protein. J Lipid Res 64:100365.","journal-title":"J Lipid Res"},{"year":"2013","author":"Beer MC","key":"ref17","unstructured":"de Beer MC, Wroblewski JM, Noffsinger VP, Ji A, Meyer JM, van der Westhuyzen DR, de Beer FC, Webb NR (2013) The Impairment of Macrophage-to-Feces Reverse Cholesterol Transport during Inflammation Does Not Depend on Serum Amyloid A. J Lipids 2013:283486."},{"key":"ref18","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1615\/CritRevImmunol.v32.i4.40","article-title":"Immune functions of serum amyloid A","volume":"32","author":"Eklund KK","year":"2012","unstructured":"Eklund KK, Niemi K, Kovanen PT (2012) Immune functions of serum amyloid A. Crit Rev Immunol 32:335\u201348.","journal-title":"Crit Rev Immunol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"e34031","DOI":"10.1371\/journal.pone.0034031","article-title":"The acute phase protein Serum Amyloid A induces lipolysis and inflammation in human adipocytes through distinct pathways","volume":"7","author":"Faty A","year":"2012","unstructured":"Faty A, Ferr\u00e9 P, Commans S (2012) The acute phase protein Serum Amyloid A induces lipolysis and inflammation in human adipocytes through distinct pathways. PLoS One 7:e34031.","journal-title":"PLoS One"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e0171711","DOI":"10.1371\/journal.pone.0171711","article-title":"Toll-like receptor 2 activation and serum amyloid A regulate smooth muscle cell extracellular matrix","volume":"12","author":"Seidl SE","year":"2017","unstructured":"Seidl SE, Pessolano LG Jr, Bishop CA, Best M, Rich CB, Stone PJ, Schreiber BM (2017) Toll-like receptor 2 activation and serum amyloid A regulate smooth muscle cell extracellular matrix. PLoS One 12:e0171711.","journal-title":"PLoS One"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"20606","DOI":"10.1016\/S0021-9258(20)80768-6","article-title":"Structural prerequisites for serum amyloid A fibril formation","volume":"268","author":"Beer MC","year":"1993","unstructured":"de Beer MC, de Beer FC, McCubbin WD, Kay CM, Kindy MS (1993) Structural prerequisites for serum amyloid A fibril formation. J Biol Chem 268:20606\u201312.","journal-title":"J Biol Chem"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/76216","article-title":"Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis","volume":"6","author":"Yan SD","year":"2000","unstructured":"Yan SD, Zhu H, Zhu A, Golabek A, Du H, Roher A, Yu J, Soto C, Schmidt AM, Stern D, Kindy M (2000) Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis. Nat Med 6:643\u20135.","journal-title":"Nat Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0022-2275(20)39863-1","article-title":"Serum amyloid A (SAA): influence on HDL-mediated cellular cholesterol efflux","volume":"36","author":"Banka CL","year":"1995","unstructured":"Banka CL, Yuan T, de Beer MC, Kindy M, Curtiss LK, de Beer FC (1995) Serum amyloid A (SAA): influence on HDL-mediated cellular cholesterol efflux. J Lipid Res 36:1058\u201365.","journal-title":"J Lipid Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13075-016-1009-y","article-title":"Differential response of serum amyloid A to different therapies in early rheumatoid arthritis and its potential value as a disease activity biomarker","volume":"18","author":"Hwang YG","year":"2016","unstructured":"Hwang YG, Balasubramani GK, Metes ID, Levesque MC, Bridges SL Jr, Moreland LW (2016) Differential response of serum amyloid A to different therapies in early rheumatoid arthritis and its potential value as a disease activity biomarker. Arthritis Res Ther 18:108.","journal-title":"Arthritis Res Ther"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1161\/01.ATV.14.9.1475","article-title":"Serum amyloid A protein family. Differential induction by oxidized lipids in mouse strains","volume":"14","author":"Liao F","year":"1994","unstructured":"Liao F, Lusis AJ, Berliner JA, Fogelman AM, Kindy M, de Beer MC, de Beer FC (1994) Serum amyloid A protein family. Differential induction by oxidized lipids in mouse strains. Arterioscler Thromb 14:1475\u20139.","journal-title":"Arterioscler Thromb"},{"key":"ref26","first-page":"287","article-title":"Molecular and cellular biology of serum amyloid A","volume":"7","author":"Rienhoff HY","year":"1990","unstructured":"Rienhoff HY Jr, Huang JH, Li XX, Liao WS (1990) Molecular and cellular biology of serum amyloid A. Mol Biol Med 7:287\u201398.","journal-title":"Mol Biol Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"172555","DOI":"10.2174\/0929867323666160418114600","article-title":"Structure and Expression of Different Serum Amyloid A (SAA) Variants and their Concentration-Dependent Functions During Host Insults","volume":"23","author":"Buck M","year":"2016","unstructured":"De Buck M, Gouwy M, Wang JM, Van Snick J, Opdenakker G, Struyf S, Van Damme J (2016) Structure and Expression of Different Serum Amyloid A (SAA) Variants and their Concentration-Dependent Functions During Host Insults. Curr Med Chem 23:172555.","journal-title":"Curr Med Chem"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1006\/geno.1994.1530","article-title":"Organization of the region encompassing the human serum amyloid A (SAA) gene family on chromosome 11p15.1","volume":"23","author":"Sellar GC","year":"1994","unstructured":"Sellar GC, Oghene K, Boyle S, Bickmore WA, Whitehead AS (1994) Organization of the region encompassing the human serum amyloid A (SAA) gene family on chromosome 11p15.1. Genomics 23:492\u20135.","journal-title":"Genomics"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bbi.2018.06.010","article-title":"Principles of inflammasome priming and inhibition: Implications for psychiatric disorders","volume":"73","author":"Herman FJ","year":"2018","unstructured":"Herman FJ, Pasinetti GM (2018) Principles of inflammasome priming and inhibition: Implications for psychiatric disorders. Brain Behav Immun 73:66\u201384.","journal-title":"Brain Behav Immun"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1111\/bph.14569","article-title":"Neuroimmune nexus of depression and dementia: Shared mechanisms and therapeutic targets","volume":"176","author":"Herman FJ","year":"2019","unstructured":"Herman FJ, Simkovic S, Pasinetti GM (2019) Neuroimmune nexus of depression and dementia: Shared mechanisms and therapeutic targets. Br J Pharmacol 176:3558\u20133584.","journal-title":"Br J Pharmacol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12974-019-1498-0","article-title":"NLRP3 inflammasome as a potential treatment in ischemic stroke concomitant with diabetes","volume":"16","author":"Hong P","year":"2019","unstructured":"Hong P, Gu RN, Li FX, Xiong XX, Liang WB, You ZJ, Zhang HF (2019) NLRP3 inflammasome as a potential treatment in ischemic stroke concomitant with diabetes. J Neuroinflammation 16:121.","journal-title":"J Neuroinflammation"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.coi.2008.01.003","article-title":"NLR, the nucleotide-binding domain leucine-rich repeat containing gene family","volume":"20","author":"Ye Z","year":"2008","unstructured":"Ye Z, Ting JP (2008) NLR, the nucleotide-binding domain leucine-rich repeat containing gene family. Curr Opin Immunol 20:3\u20139.","journal-title":"Curr Opin Immunol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/sj.cdd.4402038","article-title":"Inflammatory caspases and inflammasomes: master switches of inflammation","volume":"14","author":"Martinon F","year":"2007","unstructured":"Martinon F, Tschopp J (2007) Inflammatory caspases and inflammasomes: master switches of inflammation. Cell Death Differ 14:10\u201322.","journal-title":"Cell Death Differ"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.coi.2009.01.006","article-title":"Sensing pathogens and danger signals by the inflammasome","volume":"21","author":"Pedra JH","year":"2009","unstructured":"Pedra JH, Cassel SL, Sutterwala FS (2009) Sensing pathogens and danger signals by the inflammasome. Curr Opin Immunol 21:10\u201316.","journal-title":"Curr Opin Immunol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"582","DOI":"10.2174\/1570159X17666181227170053","article-title":"NLRP3 Inflammasome in the Pathophysiology of Hemorrhagic Stroke: A Review","volume":"17","author":"Luo Y","year":"2019","unstructured":"Luo Y, Reis C, Chen S (2019) NLRP3 Inflammasome in the Pathophysiology of Hemorrhagic Stroke: A Review. Curr Neuropharmacol 17:582\u2013589.","journal-title":"Curr Neuropharmacol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1080\/1061186X.2018.1564925","article-title":"NLRP3 inflammasome contributes to neurovascular unit damage in stroke","volume":"27","author":"Sun J","year":"2019","unstructured":"Sun J, Chi L, He Z, Gao Y, Gao Y, Huang Y, Nan G (2019) NLRP3 inflammasome contributes to neurovascular unit damage in stroke. J Drug Target 27:866\u2013875.","journal-title":"J Drug Target"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3389\/fphys.2019.00141","article-title":"The Role of Connexin and Pannexin Channels in Perinatal Brain Injury and Inflammation","volume":"10","author":"Zhou KQ","year":"2019","unstructured":"Zhou KQ, Green CR, Bennet L, Gunn AJ, Davidson JO (2019) The Role of Connexin and Pannexin Channels in Perinatal Brain Injury and Inflammation. Front Physiol 10:141.","journal-title":"Front Physiol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/s41583-018-0055-7","article-title":"Inflammasome signalling in brain function and neurodegenerative disease","volume":"19","author":"Heneka MT","year":"2018","unstructured":"Heneka MT, McManus RM, Latz E (2018) Inflammasome signalling in brain function and neurodegenerative disease. Nat Rev Neurosci 19:610\u2013621.","journal-title":"Nat Rev Neurosci"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s10571-017-0526-9","article-title":"The NLRP3 Inflammasome: An Important Driver of Neuroinflammation in Hemorrhagic Stroke","volume":"38","author":"Yang SJ","year":"2018","unstructured":"Yang SJ, Shao GF, Chen JL, Gong J (2018) The NLRP3 Inflammasome: An Important Driver of Neuroinflammation in Hemorrhagic Stroke. Cell Mol Neurobiol 38:595\u2013603.","journal-title":"Cell Mol Neurobiol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/bpa.12476","article-title":"A brain in flame; do inflammasomes and pyroptosis influence stroke pathology?","volume":"27","author":"Barrington J","year":"2017","unstructured":"Barrington J, Lemarchand E, Allan SM (2017) A brain in flame; do inflammasomes and pyroptosis influence stroke pathology? Brain Pathol 27:205\u2013212.","journal-title":"Brain Pathol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"9465","DOI":"10.1523\/JNEUROSCI.0801-19.2019","article-title":"Serum amyloid A-mediated inflammasome activation of microglial cells in cerebral ischemia","volume":"39","author":"Yu J","year":"2019","unstructured":"Yu J, Zhu H, Taheri S, Mondy W, Bonilha L, Magwood GS, Lackland D, Adams RJ, Kindy MS (2019) Serum amyloid A-mediated inflammasome activation of microglial cells in cerebral ischemia. J Neurosci 39:9465\u20139476.","journal-title":"J Neurosci"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jns.2017.07.012","article-title":"Association of SAA gene polymorphism with ischemic stroke in northern Chinese Han population","volume":"380","author":"Zhao J","year":"2017","unstructured":"Zhao J, Piao X, Wu Y, Xu P, He Z (2017) Association of SAA gene polymorphism with ischemic stroke in northern Chinese Han population. J Neurol Sci 380:101\u2013105.","journal-title":"J Neurol Sci"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1161\/STROKEAHA.115.012166","article-title":"Inflammatory Markers and Outcomes After Lacunar Stroke: Levels of Inflammatory Markers in Treatment of Stroke Study","volume":"47","author":"Boehme AK","year":"2016","unstructured":"Boehme AK, McClure LA, Zhang Y, Luna JM, Del Brutto OH, Benavente OR, Elkind MS (2016) Inflammatory Markers and Outcomes After Lacunar Stroke: Levels of Inflammatory Markers in Treatment of Stroke Study. Stroke 47:659\u201367.","journal-title":"Stroke"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"13257","DOI":"10.1074\/jbc.RA118.002428","article-title":"High-density lipoprotein inhibits serum amyloid A-mediated reactive oxygen species generation and NLRP3 inflammasome activation","volume":"293","author":"Shridas P","year":"2018","unstructured":"Shridas P, De Beer MC, Webb NR (2018) High-density lipoprotein inhibits serum amyloid A-mediated reactive oxygen species generation and NLRP3 inflammasome activation. J Biol Chem 293:13257\u201313269.","journal-title":"J Biol Chem"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12974-018-1205-6","article-title":"Serum amyloid A primes microglia for ATP-dependent interleukin-1\u03b2 release","volume":"15","author":"Facci L","year":"2018","unstructured":"Facci L, Barbierato M, Zusso M, Skaper SD, Giusti P (2018) Serum amyloid A primes microglia for ATP-dependent interleukin-1\u03b2 release. J Neuroinflammation 15:164.","journal-title":"J Neuroinflammation"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"e96703","DOI":"10.1371\/journal.pone.0096703","article-title":"Serum amyloid A induces NLRP-3-mediated IL-1\u03b2 secretion in neutrophils","volume":"9","author":"Migita K","year":"2014","unstructured":"Migita K, Izumi Y, Jiuchi Y, Kozuru H, Kawahara C, Nakamura M, Nakamura T, Agematsu K, Masumoto J, Yasunami M, Kawakami A, Eguchi K (2014) Serum amyloid A induces NLRP-3-mediated IL-1\u03b2 secretion in neutrophils. PLoS One 9:e96703.","journal-title":"PLoS One"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1161\/STROKEAHA.116.013719","article-title":"Inflammatory Biomarkers in Childhood Arterial Ischemic Stroke: Correlates of Stroke Cause and Recurrence","volume":"47","author":"Fullerton HJ","year":"2016","unstructured":"Fullerton HJ, deVeber GA, Hills NK, Dowling MM, Fox CK, Mackay MT, Kirton A, Yager JY, Bernard TJ, Hod EA, Wintermark M, Elkind MS; VIPS Investigators (2016) Inflammatory Biomarkers in Childhood Arterial Ischemic Stroke: Correlates of Stroke Cause and Recurrence. Stroke 47:2221\u20138.","journal-title":"Stroke"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1161\/ATVBAHA.118.310979","article-title":"Serum Amyloid A Is an Exchangeable Apolipoprotein","volume":"38","author":"Wilson PG","year":"2018","unstructured":"Wilson PG, Thompson JC, Shridas P, McNamara PJ, de Beer MC, de Beer FC, Webb NR, Tannock LR (2018) Serum Amyloid A Is an Exchangeable Apolipoprotein. Arterioscler Thromb Vasc Biol 38:1890\u20131900.","journal-title":"Arterioscler Thromb Vasc Biol"},{"year":"2019","author":"Wicker E","key":"ref49","unstructured":"Wicker E, Benton L, George K, Furlow W, Villapol S (2019) Serum Amyloid A Protein as a Potential Biomarker for Severity and Acute Outcome in Traumatic Brain Injury. Biomed Res Int 2019:5967816."},{"key":"ref50","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.cell.2015.08.061","article-title":"An IL-23R\/IL-22 Circuit Regulates Epithelial Serum Amyloid A to Promote Local Effector Th17 Responses","volume":"163","author":"Sano T","year":"2015","unstructured":"Sano T, Huang W, Hall JA, Yang Y, Chen A, Gavzy SJ, Lee JY, Ziel JW, Miraldi ER, Domingos AI, Bonneau R, Littman DR (2015) An IL-23R\/IL-22 Circuit Regulates Epithelial Serum Amyloid A to Promote Local Effector Th17 Responses. Cell 163:381\u201393.","journal-title":"Cell"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"4640","DOI":"10.4049\/jimmunol.1201904","article-title":"The alternative complement pathway propagates inflammation and injury in murine ischemic stroke","volume":"189","author":"Elvington A","year":"2012","unstructured":"Elvington A, Atkinson C, Zhu H, Yu J, Takahashi K, Stahl GL, Kindy MS, Tomlinson S (2012) The alternative complement pathway propagates inflammation and injury in murine ischemic stroke. J Immunol 189:4640\u20137.","journal-title":"J Immunol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"5900","DOI":"10.1523\/JNEUROSCI.22-14-05900.2002","article-title":"Inflammation-dependent cerebral deposition of serum amyloid a protein in a mouse model of amyloidosis","volume":"22","author":"Guo JT","year":"2002","unstructured":"Guo JT, Yu J, Grass D, de Beer FC, Kindy MS (2002) Inflammation-dependent cerebral deposition of serum amyloid a protein in a mouse model of amyloidosis. J Neurosci 22:5900\u20139.","journal-title":"J Neurosci"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1096\/fj.01-0133com","article-title":"Expression of serum amyloid A genes in mouse brain: unprecedented response to inflammatory mediators","volume":"15","author":"Tucker PC","year":"2001","unstructured":"Tucker PC, Sack GH Jr (2001) Expression of serum amyloid A genes in mouse brain: unprecedented response to inflammatory mediators. FASEB J 15:2241\u20136.","journal-title":"FASEB J"},{"key":"ref54","first-page":"277","article-title":"Targeted treatment for amyloidosis","volume":"16","author":"Pepys-Vered ME","year":"2014","unstructured":"Pepys-Vered ME, Pepys MB (2014) Targeted treatment for amyloidosis. Isr Med Assoc J 16:277\u201380.","journal-title":"Isr Med Assoc J"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/ki.2014.368","article-title":"Emerging treatments for amyloidosis","volume":"87","author":"Sayed RH","year":"2015","unstructured":"Sayed RH, Hawkins PN, Lachmann HJ (2015) Emerging treatments for amyloidosis. Kidney Int 87:516\u201326.","journal-title":"Kidney Int"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1159\/000356320","article-title":"Drug therapy in stroke: from preclinical to clinical studies","volume":"92","author":"Kaur H","year":"2013","unstructured":"Kaur H, Prakash A, Medhi B (2013) Drug therapy in stroke: from preclinical to clinical studies. Pharmacology 92:324\u201334.","journal-title":"Pharmacology"},{"key":"ref57","first-page":"37","article-title":"The failure of animal models of neuroprotection in acute ischemic stroke to translate to clinical efficacy","volume":"19","author":"Xu SY","year":"2013","unstructured":"Xu SY, Pan SY (2013) The failure of animal models of neuroprotection in acute ischemic stroke to translate to clinical efficacy. Med Sci Monit Basic Res 19:37\u201345.","journal-title":"Med Sci Monit Basic Res"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.amjmed.2018.10.019","article-title":"Management of Acute Ischemic Stroke","volume":"132","author":"Xiong Y","year":"2019","unstructured":"Xiong Y, Manwani B, Fisher M (2019) Management of Acute Ischemic Stroke. Am J Med 132:286\u2013291.","journal-title":"Am J Med"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"104331","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.104331","article-title":"Contribution of Onset-to-Alarm Time to Prehospital Delay in Patients with Ischemic Stroke","volume":"28","author":"Gonzalez-Aquines A","year":"2019","unstructured":"Gonzalez-Aquines A, Cordero-P\u00e9rez AC, Cristobal-Ni\u00f1o M, P\u00e9rez-V\u00e1zquez G, G\u00f3ngora-Rivera F; GECEN Investigators (2019) Contribution of Onset-to-Alarm Time to Prehospital Delay in Patients with Ischemic Stroke. J Stroke Cerebrovasc Dis 28:104331.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/ene.13859","article-title":"Aspiration versus STEnt-Retriever (ASTER) trial investigators (2019) Hemorrhagic transformation after stroke: inter- and intrarater agreement","volume":"26","author":"Guenego A","unstructured":"Guenego A, Lecler A, Raymond J, Sabben C, Khoury N, Premat K, Botta D, Boisseau W, Ma\u00efer B, Ciccio G, Redjem H, Smajda S, Ducroux C, Di Meglio L, Davy V, Olivot JM, Wang A, Duplantier J, Roques M, Krystal S, Koskas P, Collin A, Ben Maacha M, Hamdani M, Zuber K, Blanc R, Piotin M, Fahed R; Aspiration versus STEnt-Retriever (ASTER) trial investigators (2019) Hemorrhagic transformation after stroke: inter- and intrarater agreement. Eur J Neurol 26:476\u2013482.","journal-title":"Eur J Neurol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJMoa1504942","article-title":"Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component","volume":"373","author":"Richards DB","year":"2015","unstructured":"Richards DB, Cookson LM, Berges AC, Barton SV, Lane T, Ritter JM, Fontana M, Moon JC, Pinzani M, Gillmore JD, Hawkins PN, Pepys MB (2015) Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component. N Engl J Med 373:1106\u201314.","journal-title":"N Engl J Med"},{"year":"2018","author":"Richards DB","key":"ref62","unstructured":"Richards DB, Cookson LM, Barton SV, Liefaard L, Lane T, Hutt DF, Ritter JM, Fontana M, Moon JC, Gillmore JD, Wechalekar A, Hawkins PN, Pepys MB (2018) Repeat doses of antibody to serum amyloid P component clear amyloid deposits in patients with systemic amyloidosis. Sci Transl Med 10:pii:eaan3128."},{"key":"ref63","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1194\/jlr.M005413","article-title":"Impact of serum amyloid A on high density lipoprotein composition and levels","volume":"51","author":"Beer MC","year":"2010","unstructured":"de Beer MC, Webb NR, Wroblewski JM, Noffsinger VP, Rateri DL, Ji A, van der Westhuyzen DR, de Beer FC (2010) Impact of serum amyloid A on high density lipoprotein composition and levels. J Lipid Res 51:3117\u20133125.","journal-title":"J Lipid Res"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"e108564","DOI":"10.1371\/journal.pone.0108564","article-title":"Deletion of serum amyloid A3 improves high fat high sucrose diet-induced adipose tissue inflammation and hyperlipidemia in female mice","volume":"9","author":"Hartigh LJ","year":"2014","unstructured":"den Hartigh LJ, Wang S, Goodspeed L, Ding Y, Averill M, Subramanian S, Wietecha T, O'Brien KD, Chait A (2014) Deletion of serum amyloid A3 improves high fat high sucrose diet-induced adipose tissue inflammation and hyperlipidemia in female mice. PLoS One 9:e108564.","journal-title":"PLoS One"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"e1000412","DOI":"10.1371\/journal.pbio.1000412","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"8","author":"Kilkenny C","year":"2010","unstructured":"Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG (2010) Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol 8:e1000412.","journal-title":"PLoS Biol"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s12975-012-0209-2","article-title":"RIGOR guidelines: escalating STAIR and STEPS for effective translational research","volume":"4","author":"Lapchak PA","year":"2013","unstructured":"Lapchak PA, Zhang JH, Noble-Haeusslein LJ (2013) RIGOR guidelines: escalating STAIR and STEPS for effective translational research. Transl Stroke Res 4:279\u201385.","journal-title":"Transl Stroke Res"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1161\/01.STR.0000071760.66720.5F","article-title":"Fibroblast growth factor-18 reduced infarct volumes and behavioral deficits after transient occlusion of the middle cerebral artery in rats","volume":"34","author":"Ellsworth JL","year":"2003","unstructured":"Ellsworth JL, Garcia R, Yu J, Kindy MS (2003) Fibroblast growth factor-18 reduced infarct volumes and behavioral deficits after transient occlusion of the middle cerebral artery in rats. Stroke 34:1507\u201312.","journal-title":"Stroke"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/jcbfm.2012.209","article-title":"Nanoparticles for targeted delivery of antioxidant enzymes to the brain after cerebral ischemia and reperfusion injury","volume":"33","author":"Yun X","year":"2013","unstructured":"Yun X, Maximov VD, Yu J, Zhu H, Vertegel AA, Kindy MS (2013) Nanoparticles for targeted delivery of antioxidant enzymes to the brain after cerebral ischemia and reperfusion injury. J Cereb Blood Flow Metab 33:583\u201392.","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.brainres.2008.08.053","article-title":"Motoneuronotrophic factor analog GM6 reduces infarct volume and behavioral deficits following transient ischemia in the mouse","volume":"1238","author":"Yu J","year":"2008","unstructured":"Yu J, Zhu H, Ko D, Kindy MS (2008) Motoneuronotrophic factor analog GM6 reduces infarct volume and behavioral deficits following transient ischemia in the mouse. Brain Res 1238:143\u201353.","journal-title":"Brain Res"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/00004647-199804000-00004","article-title":"A reproducible model of middle cerebral artery occlusion in mice. Hemodynamic, biochemical, and magnetic resonance imaging","volume":"18","author":"Hata R","year":"1998","unstructured":"Hata R, Mies G, Wiessner C, Fritze K, Hesselbarth D, Brinker G, Hossmann KA (1998) A reproducible model of middle cerebral artery occlusion in mice. Hemodynamic, biochemical, and magnetic resonance imaging. J Cereb Blood Flow Metab 18:367\u201375.","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/s12974-015-0464-8","article-title":"Modulation of post-stroke degenerative and regenerative processes and subacute protection by site-targeted inhibition of the alternative pathway of complement","volume":"12","author":"Alawieh A","year":"2015","unstructured":"Alawieh A, Elvington A, Zhu H, Yu J, Kindy MS, Atkinson C, Tomlinson S (2015) Modulation of post-stroke degenerative and regenerative processes and subacute protection by site-targeted inhibition of the alternative pathway of complement. J Neuroinflammation 12:247.","journal-title":"J Neuroinflammation"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.neuroscience.2013.07.017","article-title":"Oral administration of glutathione improves memory deficits following transient brain ischemia by reducing brain oxidative stress","volume":"250","author":"Yabuki Y","year":"2013","unstructured":"Yabuki Y, Fukunaga K (2013) Oral administration of glutathione improves memory deficits following transient brain ischemia by reducing brain oxidative stress. Neuroscience 250:394\u2013407.","journal-title":"Neuroscience"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/ejn.14223","article-title":"Inhibition of calcium\/calmodulin-dependent protein kinase kinase (CaMKK) exacerbates impairment of endothelial cell and blood-brain barrier after stroke","volume":"49","author":"Sun P","year":"2019","unstructured":"Sun P, Bu F, Min JW, Munshi Y, Howe MD, Liu L, Koellhoffer EC, Qi L, McCullough LD, Li J (2019) Inhibition of calcium\/calmodulin-dependent protein kinase kinase (CaMKK) exacerbates impairment of endothelial cell and blood-brain barrier after stroke. Eur J Neurosci 49:27\u201339.","journal-title":"Eur J Neurosci"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1038\/s41598-020-59997-y","article-title":"MiR-34a Interacts with Cytochrome c and Shapes Stroke Outcomes","volume":"10","author":"Hu H","year":"2020","unstructured":"Hu H, Hone EA, Provencher EAP, Sprowls SA, Farooqi I, Corbin DR, Sarkar SN, Hollander JM, Lockman PR, Simpkins JW, Ren X (2020) MiR-34a Interacts with Cytochrome c and Shapes Stroke Outcomes. Sci Rep 10:3233.","journal-title":"Sci Rep"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1042\/bj3320721","article-title":"Adenoviral expression of murine serum amyloid A proteins to study amyloid fibrillogenesis","volume":"332","author":"Kindy MS","year":"1998","unstructured":"Kindy MS, King AR, Yu J, Gerardot C, Whitley J, de Beer FC (1998) Adenoviral expression of murine serum amyloid A proteins to study amyloid fibrillogenesis. Biochem J 332:721\u20138.","journal-title":"Biochem J"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/MOL.0000000000000616","article-title":"Role of serum amyloid A in atherosclerosis","volume":"30","author":"Shridas P","year":"2019","unstructured":"Shridas P, Tannock LR (2019) Role of serum amyloid A in atherosclerosis. Curr Opin Lipidol 30:320\u2013325.","journal-title":"Curr Opin Lipidol"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3109\/13506120009146822","article-title":"Amyloid formation in the rat: adenoviral expression of mouse serum amyloid A proteins","volume":"7","author":"Yu J","year":"2000","unstructured":"Yu J, Guo JT, Zhu H, Kindy MS (2000) Amyloid formation in the rat: adenoviral expression of mouse serum amyloid A proteins. Amyloid 7:32\u201340.","journal-title":"Amyloid"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3258406\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3258406\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T17:26:12Z","timestamp":1726680372000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3258406\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,8]]},"references-count":77,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-3258406\/v1","relation":{},"subject":[],"published":{"date-parts":[[2023,9,8]]},"subtype":"preprint"}}